HomePhilippine Scientific Journalvol. 56 no. 2 (2023)

The Prevalence of Gestational Diabetes Mellitus Using the IADPSG Criteria and its Risk Factors Among Filipino Women in a Tertiary Hospital: A Single-Center Study

Bernadette L. Dela Cruz | Marjorie A. Santos

Discipline: medicine (non-specific)

 

Abstract:

Background: The worldwide prevalence of gestational diabetes mellitus (GDM) vary from <1 to 28% depending on the race, country and diagnostic criteria used. The Philippine Obstetrical and Gynecological Society (POGS) endorses the IADPSG criteria which places the prevalence rate of pregnant Filipino women as high as 29.27%. Filipino women are predisposed to GDM due to multiple factors. Identifying these risk factors will improve pregnancy outcome and prevent long-term complications. Objective: To determine the prevalence of GDM in Filipino women and its associated risk factors, which includes establishing risk assessment system and comparing pregnancy outcome of women with and without GDM. Methods: This is a retrospective study that involved 120 Filipino women who had their prenatal check-up and delivery in MCU OB Clinical Division. GDM was diagnosed using the IADPSG criteria and the prevalence was computed. Results were compared to determine risk factors associated with GDM. Results: The prevalence of GDM in MCU OB Clinical Division from 2018 to 2021 ranged from 6.5% to 19.8%. There was a significant difference between the 75g OGTT results of women with and without GDM with a p < 0.001. Modifiable and nonmodifiable risk factors revealed women who later develop GDM were older (p = 0.007), had greater pre-pregnancy weight (p < .001) and higher BMI (p < .001) than those without GDM. They also have history of PCOS (p = .045) and a family history of DM (p < .001). Women with past history of GDM were more likely to develop GDM on succeeding pregnancies (p < 0.001). Women with GDM were heavier during admission (p < .001). However, there was no significant difference between the weight gain of women with and without GDM (p = .480). Pregnancy outcome was compared and majority of women with GDM delivered by primary cesarean section (25.9%) and assisted vaginal delivery (25.9%). There was no significant difference between the incidence of large for gestational age and fetal macrosomia in women with and without GDM with a p- value of 0.637 and 0.401, respectively. Conclusions: The overall prevalence of GDM was 16.7% from 2018 to 2021 with the prevalence (6.5%) noted in 2020 during the COVID-19 Pandemic due to the closure of the OPD. In this study, the identified risk factors for GDM were older (32 ± 4.993), had greater pre-pregnancy weight (66.556 ± 7.949), higher BMI (26.596 ± 3.036), history of PCOS, family history of diabetes and weigh more during admission (75.685 ± 8.935) than those without GDM. Although, majority of women with GDM underwent cesarean delivery (25.9%) and assisted vaginal delivery (25.9%), there were no other significant difference between the outcomes of women with and without GDM.



References:

  1. Roux-Ong, CJ & Tolentino-Orlina, P. Normal glucose metabolism in pregnancy. Clin Prac Guid on Diab Mel in Preg. 2018 3:7-10.
  2. Sweeting AN, Ross GP, Hyett J, & Wong J. Gestational diabetes in the first trimester: is early testing justified? Lancet Diabetes Endocrinol. 2017 5:571-
  3. Doi:10.1016/S2213-8587(17)30066-9
  4. Huhn E, Rossi S, Hoesli I, & Gobl C. Controversies in screening and diagnostic criteria for gestational diabetes in early and late pregnancy. Front. Endocrinol. 2019 9:696. DOI: 10.3389/fendo2018.90696
  5. Osgood ND, Dyck RF & Grassman WK. The inter- and intragenerational impact of gestational diabetes on the epidemic of type 2 diabetes. Am J Public Health 2011;101:173-9
  6. Egan AM, Hod M, Mahmood T & Dunne FP. Perspective on diagnostic strategies for hyperglycemia in pregnancy – dealing with the barriers and challenges:        Europe.        Diabetes       Res       Clin       Pract.       2018.       Doi: 10.1016/j.diabres.2018.06.001
  7. American Diabetes Association: Gestational Diabetes Mellitus. Diabetes Care, 27, (Suppl 1), 2004
  8. Pineda-Cortel MRB, Manalo MEM, Canivel RRC, Matias III RS, Dizon AJB, et al. Screening and Diagnosis of Gestational Diabetes Mellitus Using 75-g Oral  Glucose Tolerance Test Following the WHO, ADA, and IADPSG Criteria. J Diabetes Metab 2018, 9: 799. doi:10.4172/2155-6156.1000799
  9. Litonjua, AD, Boedisantoso R, Serirat S, Zaini A: AFES Study group on diabetes in pregnancy (ASGODIP): preliminary data on prevalence. Mar-Apr., 1996, Phil. J. Int Med, 34:67
  10. Sumpaico, WW & Perez-Santiago, MCM. Screening and detection.Clin Prac Guid on Diab Mel in Preg. 2018 3:28-29
  11. Coustan DR, Lowe LP, Metzger BE & Dyer AR. The HAPO Study: paving the way for new diagnostic criteria for GDM. Am J Obstet Gynecol. 2010 June; 202(6): 654.e1-654.e6. doi:10.1016/j.ajog.2010.04.006.
  12.  American Diabetes Association. Classification and diagnosis of diabetes: standards     of medical care in diabetes. Diabetes Care 2018 41(Suppl.1); S13-27.  Lim-Uy SW, Cunanan EC & Andag-Silva AA. Prevalence and risk factors of    gestational diabetes mellitus at the University of Santo Tomas Hospital. Philippine   Journal of Internal Medicine (2010) Vol 48 Number 1 Jan-Feb. 
  13. Ramos-Levi AM, Perez-Ferre, N, Fernandez MD, Del Valle L, Bordiu E, Bedia AR, Herraiz MA, Torrejon MJ & Calle-Pascual AL. Risk factors for gestational diabetes mellitus in a large population of women living in Spain: implications for preventive strategies. International Journal of Endocrinology Vol 2012, Article ID 312529, 9 pages doi:10.1155/2012/312529.
  14. Fathy WM, Khalil NA, & Mahmoud NS. Risk factors for gestational diabetes mellitus among pregnant women attending Monshaat Sultan Family Health Center, Menoufia Governorate. Mencufia Med J 2016 31:640-645.
  15. Larrabure-Torrealva GT, Martinez S, Luque-Fernandez MA, Sanchez SE, Mascaro PA, Ingar H, Castillo W, Zumaeta R, Grande M, Motta V, Pacora P, Gelaye B & Williams MA. Prevalence and risk factors of gestational diabetes mellitus: findings from a universal screening feasibility program in Lima, Peru.BMC             pregnancy             and             Childbirth             (2018)             18:303. https://doi.org/10.1186/s12884-018-1904-0
  16. Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018;19(11):3342. Published 2018 Oct 26. doi:10.3390/ijms19113342
  17. Urbanozo H, & Tan ITI. Association of Gestational Diabetes Mellitus Diagnosed using the IADPSG and the POGS 75 gram Oral Glucose Tolerance Test Cut-off Values with Adverse Perinatal Outcomes in the Philippine General Hospital. JAFES 2014, 29(2), 157. Retrieved from https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/148
  18. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998; 6 Suppl 2:51S.
  19. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894:i.
  20. Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome? J. Matern. Fetal Neonatal Med. 2008, 21, 149–157. [CrossRef] [PubMed] 
  21. Lee SC, Pu YB, Chow CC, Yeung VT, Ko GT, So WY, Li JK, Chan WB, Ma RC, Critchley JA, et al. Diabetes in Hong Kong Chinese: Evidence for familial clustering and parental effects. Diabetes Care 2000, 23, 1365–1368. [CrossRef] [PubMed]
  22. Kankaanranta H, Kauppi P, Tuomist LE, & Ilmarinen P. “Emerging comorbidities in adult asthma: risks, clinical associations, and mechanisms,” Mediators of Inflammation, vol. 2016, Article ID 3690628, 23 pages, 2016.
  23. Torres RM, Souza MDS, Coelho ACC, de Mello LM & Souza-Machado C. "Association between Asthma and Type 2 Diabetes Mellitus: Mechanisms and Impact on Asthma Control—A Literature Review", Canadian Respiratory Journal, vol. 2021.